Randall T. Peterson New Dean of the College of Pharmacy
Randall T. Peterson, Ph.D., will assume his role as dean and L.S. Skaggs Presidential Endowed Chair for Pharmacy Jan. 1, 2017.
Peterson is a Salt Lake City native, he earned his undergraduate degree in molecular biology from Brigham Young University and his Ph.D. in biochemistry from Harvard University. He is the current Charles Addison and Elizabeth Ann Sanders Associate Professor of Basic Science at Harvard Medical School, scientific director of the Massachusetts General Hospital Cardiovascular Research Center and a senior associate member of the Broad Institute.
Peterson and his colleagues were the first to use an animal model, the zebrafish, to model human diseases and then rapidly identify small molecule drug candidates for cardiovascular and nervous system disorders. Several compounds discovered by his lab are used as research tools or are preclinical drug candidates.
Peterson is a principal investigator or co-investigator on numerous National Institutes of Health (NIH) research grants, including a current $12 million award from the National Institute of Neurological Disorders and Stroke to establish a Center of Excellence to develop novel pharmaceutical countermeasures for cyanide exposure. He was the principal investigator on a prestigious National Institute of Mental Health EUREKA grant to develop psychotropic drugs using zebrafish models. EUREKA grants encourage exceptionally innovative research to accelerate scientific progress.